Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hyatt Hotels Corporation (H) vs TransMedics Group Inc (TMDX) Price & Performance

Hyatt Hotels CorporationTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Hyatt Hotels Corporation vs TransMedics Group Inc — how do they compare? Hyatt Hotels Corporation trades at $161.78 (market cap $15.02B), while TransMedics Group Inc trades at $78.15 (market cap $2.74B). The key difference: Hyatt Hotels Corporation is far larger — about 5.5× TransMedics Group Inc's market cap, and Hyatt Hotels Corporation pays a 0.38% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hyatt Hotels Corporation for 148 Days and TransMedics Group Inc for 24 Days on average.

HTMDX
Market Cap
$15.02B$2.74B
Volume
842,340949,331
Sector
Consumer CyclicalHealth
52-Week High
$202.09$150.42
52-Week Low
$135.42$61.99
Typical Hold Time
148 Days24 Days
Enterprise Value
$18.93B$3.13B
Dividend Yield
0.38%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hyatt Hotels Corporation

Hyatt Hotels (H) trades at $161.75, up 2.93% with recent earnings beats driving momentum. The stock shows neutral technical signals with mixed moving averages and oscillators. Fundamentally, revenue grew to $7.1B in 2025 but net income turned negative at -$52M, while valuation metrics remain elevated with P/E at 196.83. Recent developments include strategic partnerships with Delta Air Lines and expansion of the Essentials portfolio.

Outlook remains cautiously optimistic with analyst consensus target of $197.77 (22% upside) but high valuation and negative cash flow trends pose risks. The company's growth initiatives and brand expansion provide opportunities, though investors should monitor debt levels and profitability recovery.

TransMedics Group Inc

TransMedics Group (TMDX) trades at $78.17, down 3.58% on the day, with a bearish technical signal and mixed earnings history. The company reported strong 2025 results with $605.49M revenue and $190.29M net income, but 2026 projections show margin compression. Recent news highlights insider buying and leadership changes alongside legal investigations into fiduciary duties, creating a complex sentiment backdrop.

The stock offers growth potential with a consensus price target of $99.75, but faces risks from earnings misses, margin pressure, and ongoing legal scrutiny. Analyst consensus remains bullish with 69% buy ratings, yet investors must weigh robust profitability metrics against execution and regulatory uncertainties.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

H

No sentiment data available yet.

TMDX
95% Buy5% Sell
Avg holding period · 24 Days

About Hyatt Hotels Corporation

Hyatt is an operator of 1,162 owned (5% of total rooms) and managed and franchise (95%) properties across roughly 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, and the wellness brand Miraval. Hyatt acquired Two Roads in November 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 66% Americas, 18% Asia-Pacific, and 16% rest of world.

Read more on H →

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX →